Tuesday 5th December 2017

(6 years, 5 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Stephen Doughty Portrait Stephen Doughty
- Hansard - - - Excerpts

I absolutely agree with my hon. Friend. “It ain’t over” was the central message from STOPAIDS when we met last week. We need to get that message out there loud and clear. The challenge has not gone away, although we have seen much progress.

On the domestic front, I want to mention two issues. I would be grateful if the Minister reflected on them and perhaps discussed them with his colleagues in the Department of Health. First, we have seen the fragmentation of services. The all-party group published a report last year called “The HIV Puzzle”. It looked at some of the fragmentation of services in England since the Health and Social Care Act 2012 and some of the resulting challenges for people in accessing treatment and prevention services locally. Some worrying statistics are coming out about treatment availability in some areas. Secondly, while we welcome the trial of pre-exposure prophylaxis in England and the announcement in Wales and Scotland, in England PrEP will be available to only 10,000 people over three years. What will happen when we reach 10,000? Will we suddenly stop making PrEP available? Surely that cannot be the case. The many organisations that campaign for PrEP want to see it available to all those who need it.

I conclude by thanking all the Members who have come here today to support the debate on World AIDS Day 2017. We will never forget the millions of lives lost to AIDS, and we will continue to fight in their name for HIV and AIDS to become a thing of the past.

Philip Hollobone Portrait Mr Philip Hollobone (in the Chair)
- Hansard - -

This is an hour-long debate that will finish at 5.30 pm. Six Members are seeking to speak. I am obliged to call the first of the Front-Bench spokesmen at seven minutes past 5. There are guideline limits of five minutes for the Scottish National party, five minutes for Her Majesty’s Opposition and 10 minutes for the Minister, with three minutes for Mr Doughty to sum up the debate at the end. [Interruption.] Mr Doughty is generously declining to have the full three minutes, but he will perhaps take a minute or so. I am afraid there will have to be a time limit of three minutes so that everyone has a chance to contribute. The next speaker will be Ross Thomson.

--- Later in debate ---
Martin Whitfield Portrait Martin Whitfield (East Lothian) (Lab)
- Hansard - - - Excerpts

It is an honour to serve under your chairmanship, Mr Hollobone. I congratulate my hon. Friend the Member for Cardiff South and Penarth (Stephen Doughty) on securing this debate.

Members will be aware of the importance of the global fund, and I want to pay tribute to the important work the fund does in the diagnosis and treatment of HIV. It is clear today that without a supply of new medical tools, we are not going to meet our global goals promise to give young people the opportunity of a future free from AIDS.

In 2009 a trial showed for the first time that the risk of HIV infection can be reduced by a vaccine, and improved vaccine concepts are now entering new efficacy trials. There is no doubt that vaccine development is a long process, but vaccines are proven to be one of the most effective and cost-effective public health tools. With that in mind, I wish to pose two questions to the Minister about UK scientific innovation.

The Government recently published their industrial strategy, which placed life sciences at its centre. Will the Minister make representations to his counterparts in the Department for Business, Energy and Industrial Strategy about the need for research and development for new HIV prevention tools to be part of that?

There has been little, if any, discussion about how the industrial strategy will offset the uncertainties for UK science created by Brexit. In recent years, the European Commission has overtaken the UK to become the second-largest funder of global health research and development after the US, with many UK scientists benefiting from the pooled funding and collaboration. Will the Minister reassure UK scientists about what the future will hold?

I asked the Minister a question last week. I was grateful for his answer and for the correction yesterday to that answer for accuracy. HIV is still the greatest health challenge of our time. Although it does not quite command front-page attention any more, it must not be put to the back of the Government’s and people’s minds. Investment in research and development will keep the fight against this challenge alive.

Philip Hollobone Portrait Mr Philip Hollobone (in the Chair)
- Hansard - -

We now come to the Front-Bench speeches, the first of which will be Chris Law from the Scottish National party.